ArticleScientific reports2026

Bronchial artery infusion of PD-1 inhibitors plus chemotherapy improves progression-free survival in advanced NSCLC: a prospective cohort study.

Bin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.